Australia vs Nicaragua: The number of people with susceptibility test result for rifampicin
Australia
597
in 2021
Nicaragua
627
in 2021
Australia rank
76th
Nicaragua rank
74th
The number of people with susceptibility test result for rifampicin over time
- Australia
- Nicaragua
How they compare
Nicaragua currently reports 627 against 597 in Australia, a difference of 30.
That makes Nicaragua's figure about 1.1 times Australia's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Australia ahead.
Australia ranks 76th and Nicaragua ranks 74th of 155 countries.
Across the 2 decades both report, Australia averaged higher in 1 and Nicaragua in 1.
Head to head by decade
| Decade | Australia | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 702.67 | 675.33 | 27.33 | Australia |
| 2020s | 666 | 944.5 | 278.5 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Australia or Nicaragua?
- Nicaragua, at 627 against 597 in Australia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Australia and Nicaragua?
- 30, with Nicaragua ahead.
- How many years of comparable data are there for Australia and Nicaragua?
- 5 years are reported by both, from 2017 to 2021.
- How do Australia and Nicaragua rank globally for the number of people with susceptibility test result for rifampicin?
- Australia ranks 76th and Nicaragua ranks 74th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.